77 related articles for article (PubMed ID: 37147760)
1. A single-center retrospective study on epidemiological and Traditional Chinese Medicine syndrome characteristics of 21010 patients with reflux/heartburn symptoms.
Yanping T; Peicai LI; Xi L; Lei L; Yanxia G; Xiaodong W; Lina L; Li Y
J Tradit Chin Med; 2023 Jun; 43(3):574-581. PubMed ID: 37147760
[TBL] [Abstract][Full Text] [Related]
2. Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
Matsumura T; Sonoda M; Okimoto K; Dao HV; Takahashi S; Akizue N; Horio R; Goto C; Kurosugi A; Kaneko T; Ohta Y; Taida T; Kikuchi A; Fujie M; Kato J; Kato N
Dig Dis Sci; 2024 Jun; 69(6):2132-2139. PubMed ID: 38622462
[TBL] [Abstract][Full Text] [Related]
3. Frequency of functional esophageal disorders in patients with refractory reflux symptoms in Lima, Peru.
Piza-Palacios L; Cárdenas-Oña M; Vásquez-Ojeda X; Alurralde C; Rosas E; Samalvides-Cuba F; Espinoza-Ríos J
Rev Gastroenterol Peru; 2023; 43(3):242-250. PubMed ID: 37890849
[TBL] [Abstract][Full Text] [Related]
4. The Rome IV versus Rome III criteria for heartburn diagnosis: A comparative study.
Zhang M; Chen M; Peng S; Xiao Y
United European Gastroenterol J; 2018 Apr; 6(3):358-366. PubMed ID: 29774149
[TBL] [Abstract][Full Text] [Related]
5. Improved diagnosis of reflux hypersensitivity.
Voulgaris T; Hoshino S; Sifrim D; Yazaki E
Neurogastroenterol Motil; 2023 Dec; 35(12):e14680. PubMed ID: 37731341
[TBL] [Abstract][Full Text] [Related]
6. Recent insights on functional heartburn and reflux hypersensitivity.
Savarino E; Marabotto E; Savarino V
Curr Opin Gastroenterol; 2022 Jul; 38(4):417-422. PubMed ID: 35762702
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of functional esophageal disorders and associated clinical characteristics in patients with proton-pump-inhibitor-unresponsive reflux symptoms.
Wei MH; Chen CC; Lee HC; Lee YC; Wang HP; Wu MS; Wu JF; Tseng PH
J Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38860301
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).
Sachar M; Mautner Wizentier M; Risner E; Asmail H; Omara M; Chablaney S; Khan A; Knotts R
Surg Endosc; 2024 May; 38(5):2842-2849. PubMed ID: 38528263
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.
Kinoshita Y; Sakurai Y; Takabayashi N; Kudou K; Araki T; Miyagi T; Iwakiri K; Ashida K
Clin Transl Gastroenterol; 2019 Nov; 10(11):e00101. PubMed ID: 31770139
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the Role of Esophageal Mucosal Dilated Intercellular Spaces in the Diagnosis and Pathophysiology of Heartburn.
Gorgulu V; Ergun P; Kipcak S; Doganavsargil B; Sifrim D; Bor S
J Neurogastroenterol Motil; 2023 Oct; 29(4):436-445. PubMed ID: 37814434
[TBL] [Abstract][Full Text] [Related]
11. Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease.
Fass R; Vaezi M; Sharma P; Yadlapati R; Hunt B; Harris T; Smith N; Leifke E; Armstrong D
Aliment Pharmacol Ther; 2023 Nov; 58(10):1016-1027. PubMed ID: 37750406
[TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.
Savarino V; Pace F; Scarpignato C;
Aliment Pharmacol Ther; 2017 Mar; 45(5):631-642. PubMed ID: 28116754
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation.
Batista AO; Nascimento WV; Cassiani RA; Silva ACV; Alves LMT; Alves DC; Dantas RO
Clinics (Sao Paulo); 2020; 75():e1556. PubMed ID: 31994617
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Esophageal Function Tests in Chinese Patients with Functional Heartburn and Reflux Hypersensitivity.
Gao F; Gao Y; Chen X; Qian J; Zhang J
Gastroenterol Res Pract; 2017; 2017():3596148. PubMed ID: 29018480
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan.
Kuribayashi S; Nakamura F; Motegi SI; Hara K; Hosaka H; Sekiguchi A; Ishikawa M; Endo Y; Harada T; Sorimachi H; Obokata M; Uchida M; Yamaguchi K; Uraoka T
J Gastroenterol; 2024 Mar; 59(3):179-186. PubMed ID: 38252140
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.
Modlin IM; Hunt RH; Malfertheiner P; Moayyedi P; Quigley EM; Tytgat GN; Tack J; Heading RC; Holtman G; Moss SF;
Digestion; 2009; 80(2):74-88. PubMed ID: 19546560
[TBL] [Abstract][Full Text] [Related]
17. Association between Mean Nocturnal Baseline Impedance (MNBI) and Post-Reflux Swallow-Induced Peristaltic Wave Index (PSPW) in GERD Patients.
Sararu ER; Peagu R; Fierbinteanu-Braticevici C
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132186
[TBL] [Abstract][Full Text] [Related]
18. Update on Functional Heartburn.
Yamasaki T; O'Neil J; Fass R
Gastroenterol Hepatol (N Y); 2017 Dec; 13(12):725-734. PubMed ID: 29339948
[TBL] [Abstract][Full Text] [Related]
19. Effects of proton pump inhibitor use on the esophageal microbial community.
Tasnim S; Miller AL; Jupiter DC; Hamilton CF; Reep GL; Krill TS; Pyles RB; Okereke IC
BMC Gastroenterol; 2020 Sep; 20(1):312. PubMed ID: 32967615
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and acceptability of esophageal-directed hypnotherapy for functional heartburn.
Riehl ME; Pandolfino JE; Palsson OS; Keefer L
Dis Esophagus; 2016 Jul; 29(5):490-6. PubMed ID: 25824436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
